Eli Lilly and Company

SNSE:LLYCL Stock Report

Market Cap: CL$698.1t

Eli Lilly Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SNSE:LLYCL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Sep 24SellCL$21,581,800,255Lilly Endowment, Inc, Endowment ArmCompany24,084CL$898,406.77
27 Aug 24SellCL$21,590,597,854Lilly Endowment, Inc, Endowment ArmCompany24,552CL$882,808.82
22 Aug 24SellCL$2,836,616,982Lilly Endowment, Inc, Endowment ArmCompany3,196CL$888,174.75
10 Jul 24SellCL$181,106,713,045Lilly Endowment, Inc, Endowment ArmCompany210,000CL$867,077.12
08 Jul 24SellCL$80,651,619,382Lilly Endowment, Inc, Endowment ArmCompany93,593CL$870,747.73
05 Jul 24SellCL$44,692,587,232Lilly Endowment, Inc, Endowment ArmCompany52,369CL$854,409.49
03 Jul 24SellCL$7,584,146,991Lilly Endowment, Inc, Endowment ArmCompany8,848CL$859,422.87
01 Jul 24SellCL$50,652,071,255Lilly Endowment, Inc, Endowment ArmCompany58,749CL$863,149.89
28 Jun 24SellCL$1,242,979,432Lilly Endowment, Inc, Endowment ArmCompany1,441CL$862,581.15
25 Jun 24SellCL$159,790,005,523Lilly Endowment, Inc, Endowment ArmCompany188,100CL$854,415.46
24 Jun 24SellCL$14,633,678,037Lilly Endowment, Inc, Endowment ArmCompany17,229CL$850,342.19
20 Jun 24SellCL$8,140,476,017Lilly Endowment, Inc, Endowment ArmCompany9,671CL$843,208.46
17 Jun 24SellCL$162,354,139,530Lilly Endowment, Inc, Endowment ArmCompany194,978CL$838,531.31
14 Jun 24SellCL$12,300,431,936Lilly Endowment, Inc, Endowment ArmCompany15,022CL$819,667.85
10 Jun 24SellCL$60,015,883,027Lilly Endowment, Inc, Endowment ArmCompany75,510CL$803,443.24
07 Jun 24SellCL$108,573,175,626Lilly Endowment, Inc, Endowment ArmCompany139,490CL$782,092.69
06 Jun 24SellCL$136,903,022,362Lilly Endowment, Inc, Endowment ArmCompany179,617CL$769,945.71
05 Jun 24SellCL$15,439,001,106Lilly Endowment, Inc, Endowment ArmCompany20,383CL$758,653.95
03 Jun 24SellCL$145,176,450,001Lilly Endowment, Inc, Endowment ArmCompany192,794CL$760,481.37
31 May 24SellCL$16,770,208,071Lilly Endowment, Inc, Endowment ArmCompany22,206CL$756,225.44
29 May 24SellCL$95,880,631,269Lilly Endowment, Inc, Endowment ArmCompany130,385CL$739,269.69
28 May 24SellCL$1,490,907,071Lilly Endowment, Inc, Endowment ArmCompany2,052CL$726,562.90
24 May 24SellCL$67,472,620,412Lilly Endowment, Inc, Endowment ArmCompany92,563CL$728,937.27
23 May 24SellCL$37,401,571,739Lilly Endowment, Inc, Endowment ArmCompany50,767CL$746,285.78
22 May 24SellCL$9,449,605,749Lilly Endowment, Inc, Endowment ArmCompany12,974CL$728,349.45
21 May 24SellCL$133,373,786,541Lilly Endowment, Inc, Endowment ArmCompany186,259CL$722,755.61
16 Feb 24SellCL$128,639,037,682Lilly Endowment, Inc, Endowment ArmCompany169,684CL$769,840.81
15 Feb 24SellCL$36,959,782,457Lilly Endowment, Inc, Endowment ArmCompany50,316CL$736,290.77
09 Feb 24SellCL$148,285,389,952Lilly Endowment, Inc, Endowment ArmCompany206,257CL$723,441.73
08 Feb 24SellCL$6,261,861,616Lilly Endowment, Inc, Endowment ArmCompany8,743CL$716,214.30
31 Jan 24SellCL$47,480,196,927Lilly Endowment, Inc, Endowment ArmCompany78,573CL$618,022.06
30 Jan 24SellCL$45,897,673,027Lilly Endowment, Inc, Endowment ArmCompany76,215CL$603,195.17
29 Jan 24SellCL$32,472,122,480Lilly Endowment, Inc, Endowment ArmCompany54,032CL$600,979.47
16 Jan 24SellCL$704,784,451Lilly Endowment, Inc, Endowment ArmCompany1,180CL$597,804.18
11 Jan 24SellCL$7,123,037,531Lilly Endowment, Inc, Endowment ArmCompany12,344CL$581,595.52
10 Jan 24SellCL$94,830,761,368Lilly Endowment, Inc, Endowment ArmCompany163,730CL$584,424.17
09 Jan 24SellCL$20,051,041,316Lilly Endowment, Inc, Endowment ArmCompany34,538CL$582,021.45
04 Jan 24SellCL$8,065,928,711Lilly Endowment, Inc, Endowment ArmCompany14,388CL$561,303.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LLYCL?
Owner TypeNumber of SharesOwnership Percentage
State or Government841,8360.0935%
Individual Insiders1,192,6290.132%
General Public60,626,0726.73%
Institutions837,771,50793%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
PNC Financial Services Group Inc., Banking Investments
102,410,215CL$79.4t100%45.51%
10.8%
Lilly Endowment, Inc, Endowment Arm
96,891,978CL$75.1t-0.49%100.0%
8.19%
The Vanguard Group, Inc.
73,773,467CL$57.2t-0.12%0.83%
7.15%
BlackRock, Inc.
64,341,129CL$49.9t-2.3%0.79%
4.12%
Capital Research and Management Company
37,098,776CL$28.8t-3.95%1.35%
3.76%
State Street Global Advisors, Inc.
33,852,215CL$26.2t-0.07%0.96%
3.39%
FMR LLC
30,554,201CL$23.7t-1.78%1.38%
2.41%
T. Rowe Price Group, Inc.
21,706,138CL$16.8t0.3%1.46%
1.96%
PRIMECAP Management Company
17,690,508CL$13.7t-9.83%9.83%
1.9%
Geode Capital Management, LLC
17,090,971CL$13.3t0.5%0.92%
1.46%
JP Morgan Asset Management
13,130,692CL$10.2t-3.39%1.13%
1.4%
State Farm Insurance Companies, Asset Management Arm
12,646,138CL$9.8t0%8.73%
1.22%
Norges Bank Investment Management
11,004,852CL$8.5t0%0.68%
1.18%
Wellington Management Group LLP
10,613,796CL$8.2t-1.53%1.28%
1.08%
UBS Asset Management AG
9,711,423CL$7.5t8.87%0.73%
0.93%
Morgan Stanley, Investment Banking and Brokerage Investments
8,329,069CL$6.5t9%0.74%
0.92%
Northern Trust Global Investments
8,243,882CL$6.4t-5.37%0.96%
0.78%
Legal & General Investment Management Limited
6,986,788CL$5.4t-1.81%0.96%
0.77%
Jennison Associates LLC
6,947,395CL$5.4t-3.95%3.0%
0.65%
BNY Asset Management
5,858,720CL$4.5t-9.49%0.83%
0.64%
Eaton Vance Management
5,774,446CL$4.5t0.06%1.02%
0.56%
Fisher Asset Management, LLC
5,058,101CL$3.9t3.46%1.59%
0.56%
AllianceBernstein L.P.
5,057,736CL$3.9t3.84%1.17%
0.55%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
4,937,134CL$3.8t-1.4%0.91%
0.54%
Charles Schwab Investment Management, Inc.
4,835,446CL$3.7t0.21%0.61%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 17:41
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eli Lilly and Company is covered by 63 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Alistair CampbellBerenberg